JP3532192B2 - 毛成長の速度及び特徴の変化 - Google Patents
毛成長の速度及び特徴の変化Info
- Publication number
- JP3532192B2 JP3532192B2 JP50125792A JP50125792A JP3532192B2 JP 3532192 B2 JP3532192 B2 JP 3532192B2 JP 50125792 A JP50125792 A JP 50125792A JP 50125792 A JP50125792 A JP 50125792A JP 3532192 B2 JP3532192 B2 JP 3532192B2
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- hair growth
- composition
- alanosine
- rate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000003662 hair growth rate Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 15
- 230000003779 hair growth Effects 0.000 claims abstract description 14
- 230000000699 topical effect Effects 0.000 claims abstract description 10
- 102000005291 Adenylosuccinate synthase Human genes 0.000 claims abstract description 8
- 108010056443 Adenylosuccinate synthase Proteins 0.000 claims abstract description 8
- 102000030907 Aspartate Carbamoyltransferase Human genes 0.000 claims abstract description 6
- 108091000126 Dihydroorotase Proteins 0.000 claims abstract description 6
- ZZKNRXZVGOYGJT-VKHMYHEASA-N (2s)-2-[(2-phosphonoacetyl)amino]butanedioic acid Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)CP(O)(O)=O ZZKNRXZVGOYGJT-VKHMYHEASA-N 0.000 claims description 10
- ZGNLFUXWZJGETL-YUSKDDKASA-N (Z)-[(2S)-2-amino-2-carboxyethyl]-hydroxyimino-oxidoazanium Chemical compound N[C@@H](C\[N+]([O-])=N\O)C(O)=O ZGNLFUXWZJGETL-YUSKDDKASA-N 0.000 claims description 9
- MLFKVJCWGUZWNV-UHFFFAOYSA-N L-alanosine Natural products OC(=O)C(N)CN(O)N=O MLFKVJCWGUZWNV-UHFFFAOYSA-N 0.000 claims description 9
- 239000003098 androgen Substances 0.000 claims description 4
- 231100000252 nontoxic Toxicity 0.000 claims description 4
- 230000003000 nontoxic effect Effects 0.000 claims description 4
- QQWGVQWAEANRTK-UHFFFAOYSA-N bromosuccinic acid Chemical compound OC(=O)CC(Br)C(O)=O QQWGVQWAEANRTK-UHFFFAOYSA-N 0.000 claims description 3
- 229940125532 enzyme inhibitor Drugs 0.000 claims 2
- 239000002532 enzyme inhibitor Substances 0.000 claims 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- 229960005261 aspartic acid Drugs 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 210000000056 organ Anatomy 0.000 description 13
- 241000699800 Cricetinae Species 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 210000004209 hair Anatomy 0.000 description 6
- 210000003780 hair follicle Anatomy 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- -1 7-deaza-8-azaguanosine monophosphate Chemical class 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- ZCARDBJHSMTFCZ-UHFFFAOYSA-N 2-(phosphonomethylsulfanylmethyl)butanedioic acid Chemical compound OC(=O)CC(C(O)=O)CSCP(O)(O)=O ZCARDBJHSMTFCZ-UHFFFAOYSA-N 0.000 description 1
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 1
- NKGPJODWTZCHGF-UHFFFAOYSA-N 9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione Chemical compound OC1C(O)C(CO)OC1N1C(NC=NC2=S)=C2N=C1 NKGPJODWTZCHGF-UHFFFAOYSA-N 0.000 description 1
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 1
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 1
- 241000699673 Mesocricetus auratus Species 0.000 description 1
- CCIAZJGNPJDRLB-BXRBKJIMSA-N OC(=O)[C@@H](N)CN(O)N=O.OC(=O)[C@@H](N)CN(O)N=O Chemical compound OC(=O)[C@@H](N)CN(O)N=O.OC(=O)[C@@H](N)CN(O)N=O CCIAZJGNPJDRLB-BXRBKJIMSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- GTARKUZCYSDIEH-UMMCILCDSA-N [(2R,3S,4R,5R)-5-(5-amino-7-oxo-6H-triazolo[4,5-d]pyrimidin-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate Chemical compound N1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O GTARKUZCYSDIEH-UMMCILCDSA-N 0.000 description 1
- 150000003838 adenosines Chemical class 0.000 description 1
- MLFKVJCWGUZWNV-REOHCLBHSA-N alanosine Chemical compound OC(=O)[C@@H](N)CN(O)N=O MLFKVJCWGUZWNV-REOHCLBHSA-N 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940116298 l- malic acid Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 239000002719 pyrimidine nucleotide Substances 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A61Q7/02—Preparations for inhibiting or slowing hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Description
ギン酸トランスカルバミラーゼの阻害剤を含有した組成
物の皮膚への局所適用による哺乳動物毛成長、特にアン
ドロゲン刺激毛成長の速度及び特徴を変化させるための
方法及び組成物に関する。
載されたように、5α−レダクターゼもしくはオルニチ
ンでカルボキシラーゼの阻害剤のようなある酵素の阻害
剤又は細胞質アンドロゲンレセプター結合剤のような抗
アンドロゲン物質を皮膚に適用することにより毛成長の
速度及び特徴を変化させることが既に提案された。更
に、Richards et al,Cancer Research,Vol.42,4143−41
52(1982);DeYoung et al,Cancer Research,Vol.38,36
97−3701(1978);及びChase,Physiolo.Zool.,Vol.24,
1−8(1951)からわかるように、γ−グルタミルトラ
ンスペプチダーゼを含めた他の酵素が毛包形成又は毛成
長の様々な段階に関与していることは理論化されてきた
が、但し様々な酵素とそれらがコントロールする反応と
の関係、並びにお互いへの及び毛成長に関するそれらの
効果は十分に理解されていない。
激毛成長の速度及び特徴はアデニロコハク酸シンテター
ゼ又はアスパラギン酸トランスカルバミラーゼの阻害剤
を含有した組成物の皮膚への局所適用により変えられる
ことがここに判明した。
阻害剤としてはL−アラノシン(〔L−2−アミノ−3
−(N−ヒドロキシ,N−ニトロソアミノ)プロピオン
酸〕)、6−メルカプトプリンリボシド5′−リン酸、
8−アザグアノシン一リン酸、7−デアザ−8−アザグ
アノシン一リン酸、2′−d グアノシン一リン酸、β
−D−アラビノシルグアノシン一リン酸等がある。アス
パラギン酸トランスカルバミラーゼの阻害剤としては欧
州特許出願第328,834A号明細書で記載されたようなN−
ホスホンアセチル−L−アスパラギン酸(PALA)、2−
〔〔(ホスホノメチル)チオ〕メチル〕コハク酸、O−
ホスホノアセチル−L−リンゴ酸、ハロゲン化ホスホノ
アセチル二酸又はハロゲン化ホスホノアセチルアミノ二
酸と特にブロモサクシネートがある。これらの中ではL
−アラノシン及びPALAが好ましい。L−アラノシンはL
−アラノシル−5−アミノ−4−イミダゾールカルボン
酸リボヌクレオチドに代謝上活性化されるが、これはイ
ンビボで形成され、アデニロコハク酸シンテターゼ酵素
の直接又は近位阻害剤であることに留意すべきである。
このようにL−アラノシンは酵素の間接的阻害剤である
が、但し本発明の目的からは阻害剤という用語内に含ま
れる。
できるように適合化される無毒性の皮膚科上許容される
ビヒクル又はキャリアを含有する。組成物中における阻
害剤の濃度は飽和溶液以内の広範囲にわたり、好ましく
は0.1〜20重量%又はそれ以上で変動させることができ
る;毛成長の減少は適用される阻害剤の量が皮膚の単位
面積当たりで増加するに従い増大する。有効に適用され
る最大量は阻害剤が皮膚に浸透する速度によってのみ制
限される。通常、有効量は皮膚cm2当たり10〜2500μg
又はそれ以上の範囲である。
めであり、その範囲に関する制限として作用しない。
スして各々0.1、0.5、、1、2及び6重量%の阻害剤を
含有した標品を得、pHを水酸化ナトリウムでpH7.5に調
整した。
リアン(Golden Syrian)ハムスターを用意した。これ
らの動物はそれらが各側に1つずつ各々直径約8mmの卵
形側腹器官を示し、ヒトあごひげに似た濃い黒で粗い毛
を生やすという点でヒトあごひげ成長に関して許容され
るモデルと考えられた。これらの器官はハムスターにお
いてアンドロゲンに応答して毛を生やす。各ハムスター
の側腹器官はチオグリコール酸ベース化学脱毛剤〔サー
ジェックス(Surgex)〕を適用することにより脱毛した
が、各動物の一方の器官には1日1回ビヒクル単独10〜
25μを適用し、各動物の他方の器官には等量の阻害剤
含有ビヒクルを適用した。このような適用の3週間後に
(1週間に5日)、側腹器官を剃毛し、各々から回復し
た毛の量(毛質量)を秤量した。阻害剤による毛成長の
減少度はビヒクル単独で処理された器官と比較して阻害
剤で処理された器官における毛質量の減少率として表示
した。コントロールとして、1群の動物8匹はビヒクル
単独で処理された各動物の側腹器官を双方とも有してい
た。結果は下記表1で示されたとおりであった。
あることも観察された。
回の同様な局所処理ではハムスター毛包でアデニロコハ
ク酸シンテターゼ活性を約49%阻害することがわかっ
た。
毛包ヌクレオチドレベルの測定によって更に示された。
ハムスター8匹の群を一方の側腹器官においてL−アラ
ノシン(前記ビヒクル中10%)で局所処理し、他方の器
官は等量のビヒクルのみを受けた。3日間の連日処理
後、側腹器官から毛包を摘出し、アデノシンヌクレオチ
ド含有率を調べた。L−アラノシン処理は毛包中のAM
P、ADP及びATPレベルに関して各々50、40及び29%減少
させた。
な重量%のN−ホスホンアセチル−L−アスパラギン酸
(PALA)を含有した一連の組成物を製造し、例1で記載
された場合と同様の条件下でハムスター側腹器官に適用
した。3週間後に観察された毛成長の減少は下記のとお
りであった: PALAの10%溶液による同様な局所処理(24時間にわた
るPALAの10%溶液による2回の処理)ではハムスター毛
包でアスパラギン酸トランスカルバミラーゼ活性を72%
減少させることがわかった。
与の効果は例1でヌクレオチド含有率を調べた場合と同
様の処理プロトコールを用いて調べた。結果はUDP25
%、UTP50%、CDP19%及びCTP60%の阻害であった。
Claims (3)
- 【請求項1】無毒性の皮膚科上許容されるビヒクルと、
組成物の全重量に基づき0.1〜20%の酵素阻害剤を含ん
でなる、アンドロゲン刺激哺乳動物毛成長の速度を減少
させるための局所組成物であって、上記酵素阻害剤はア
デニロコハク酸シンテターゼの阻害剤であるL−アラノ
シン又はアスパラギン酸トランスカルバミラーゼの阻害
剤であるN−ホスホンアセチル−L−アスパラギン酸又
はブロモサクシネートから選ばれるものである、上記局
所組成物。 - 【請求項2】無毒性の皮膚科上許容されるビヒクルと、
組成物の全重量に基づき0.1〜20%のアデニロコハク酸
シンテターゼの阻害剤であるL−アラノシンを含んでな
る、哺乳動物毛成長の速度を減少させ及び特徴を変化さ
せるための局所組成物。 - 【請求項3】無毒性の皮膚科上許容されるビヒクルと、
組成物の全重量に基づき0.1〜20%のアスパラギン酸ト
ランスカルバミラーゼの阻害剤であるN−ホスホンアセ
チル−L−アスパラギン酸又はブロモサクシネートを含
んでなる、哺乳動物毛成長の速度を減少させ及び特徴を
変化させるための局所組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/603,999 US5095007A (en) | 1990-10-24 | 1990-10-24 | Alteration of rate and character of hair growth |
US603,999 | 1990-10-24 | ||
PCT/US1991/007839 WO1992007569A1 (en) | 1990-10-24 | 1991-10-22 | Alteration of rate and character of hair growth |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06502648A JPH06502648A (ja) | 1994-03-24 |
JP3532192B2 true JP3532192B2 (ja) | 2004-05-31 |
Family
ID=24417775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50125792A Expired - Lifetime JP3532192B2 (ja) | 1990-10-24 | 1991-10-22 | 毛成長の速度及び特徴の変化 |
Country Status (9)
Country | Link |
---|---|
US (1) | US5095007A (ja) |
EP (1) | EP0554363B1 (ja) |
JP (1) | JP3532192B2 (ja) |
AT (1) | ATE167625T1 (ja) |
AU (1) | AU662112B2 (ja) |
CA (1) | CA2094491C (ja) |
DE (1) | DE69129663T2 (ja) |
ES (1) | ES2117646T3 (ja) |
WO (1) | WO1992007569A1 (ja) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9118866D0 (en) * | 1991-09-04 | 1991-10-23 | Unilever Plc | Cosmetic composition |
AU670554B2 (en) * | 1991-11-05 | 1996-07-25 | Gillette Company, The | Alteration of rate and character of hair growth |
US5364885A (en) * | 1992-11-13 | 1994-11-15 | Ahluwalia Gurpreet S | Reduction of hair growth |
US5411991A (en) * | 1992-12-22 | 1995-05-02 | Shander; Douglas | Method of reducing hair growth employing sulfhydryl active compounds |
US6743419B1 (en) | 1992-12-22 | 2004-06-01 | The Gillette Company | Method of reducing hair growth employing sulfhydryl active compounds |
US5648394A (en) * | 1993-05-27 | 1997-07-15 | Boxall; Brian Alfred | Topical composition for inhibiting hair growth |
US6414017B2 (en) | 1993-05-28 | 2002-07-02 | The Gillette Company | Inhibition of hair growth |
US6239170B1 (en) | 1993-05-28 | 2001-05-29 | Gurpreet S. Ahluwalia | Inhibition of hair growth |
US5474763A (en) * | 1994-03-11 | 1995-12-12 | Shander; Douglas | Reduction of hair growth |
US5468476A (en) * | 1994-03-16 | 1995-11-21 | Ahluwalia; Gurpreet S. | Reduction of hair growth |
US5455234A (en) * | 1994-03-16 | 1995-10-03 | Ahluwalia; Gurpreet S. | Inhibition of hair growth |
US5554608A (en) * | 1994-09-28 | 1996-09-10 | Ahluwalia; Gurpreet S. | Inhibition of hair growth |
US5674477A (en) * | 1995-02-28 | 1997-10-07 | Ahluwalia; Gurpreet S. | Reduction of hair growth |
DE69622154T2 (de) * | 1995-02-28 | 2003-02-13 | Gillette Co | Verwendung von angiogenese-suppressoren zur hemmung des haarwuchses |
US5645825A (en) * | 1995-06-07 | 1997-07-08 | The Procter & Gamble Company | Depilatory compositions comprising sulfhydryl compounds |
US5728736A (en) * | 1995-11-29 | 1998-03-17 | Shander; Douglas | Reduction of hair growth |
US5652273A (en) * | 1995-11-30 | 1997-07-29 | Henry; James | Reduction of hair growth |
US6407056B1 (en) | 1996-07-12 | 2002-06-18 | Johnson & Johnson Consumer Companies, Inc. | Methods for altering hair growth and hair pigmentation by apoptosis in the follicular papillae and compositions therefor |
US5908867A (en) * | 1996-07-18 | 1999-06-01 | Henry; James P. | Reduction of hair growth |
US5840752A (en) * | 1996-11-21 | 1998-11-24 | Henry; James P. | Reduction of hair growth |
ZA9711121B (en) * | 1996-12-13 | 1998-06-23 | Handelman Joseph H | Reduction of hair growth. |
US6037326A (en) * | 1996-12-31 | 2000-03-14 | Styczynski; Peter | Reduction of hair growth |
AUPO690297A0 (en) | 1997-05-20 | 1997-06-12 | Kahale, Laura | Prevention/retardation of hair growth |
US5939458A (en) * | 1997-09-22 | 1999-08-17 | Henry; James P. | Reduction of hair growth |
US6146620A (en) * | 1997-12-09 | 2000-11-14 | Janowski; Leonard J. | Shaving compositions useful in altering the growth of male beard hair |
JP3973748B2 (ja) | 1998-01-14 | 2007-09-12 | 花王株式会社 | 発毛抑制剤 |
US5958946A (en) * | 1998-01-20 | 1999-09-28 | Styczynski; Peter | Modulation of hair growth |
US6060471A (en) * | 1998-01-21 | 2000-05-09 | Styczynski; Peter | Reduction of hair growth |
US6020006A (en) * | 1998-10-27 | 2000-02-01 | The Gillette Company | Reduction of hair growth |
US6121269A (en) * | 1999-02-22 | 2000-09-19 | Henry; James P. | Reduction of hair growth |
US6235737B1 (en) | 2000-01-25 | 2001-05-22 | Peter Styczynski | Reduction of hair growth |
US6299865B1 (en) | 2000-05-02 | 2001-10-09 | Peter Styczynski | Reduction of hair growth |
US7439271B2 (en) | 2001-06-27 | 2008-10-21 | The Gillette Company | Reduction of hair growth |
JP4759182B2 (ja) * | 2001-08-03 | 2011-08-31 | 花王株式会社 | 水溶性ショウキョウエキス |
US6743822B2 (en) | 2001-08-10 | 2004-06-01 | The Gillette Company | Reduction of hair growth |
US20030036561A1 (en) * | 2001-08-10 | 2003-02-20 | Peter Styczynski | Reduction of hair growth |
US7261878B2 (en) * | 2001-08-10 | 2007-08-28 | The Gillette Company | Reduction of hair growth |
US7374770B2 (en) * | 2001-08-15 | 2008-05-20 | Skinmedica, Inc. | Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
US6730809B2 (en) | 2001-08-29 | 2004-05-04 | Women First Healthcare, Inc. | Processes for the production of α-difluoromethyl ornithine (DFMO) |
US20040198821A1 (en) * | 2002-01-29 | 2004-10-07 | Hwang Cheng Shine | Reduction of hair growth |
US7160921B2 (en) * | 2002-01-29 | 2007-01-09 | The Gillette Company | Reduction of hair growth |
US20030199584A1 (en) * | 2002-04-11 | 2003-10-23 | Ahluwalia Gurpreet S. | Reduction of hair growth |
US20040141935A1 (en) * | 2003-01-21 | 2004-07-22 | Peter Styczynski | Reduction of hair growth |
US7015349B2 (en) * | 2003-03-26 | 2006-03-21 | The Gillette Company | Reduction of hair growth |
US20050031699A1 (en) * | 2003-06-26 | 2005-02-10 | L'oreal | Porous particles loaded with cosmetically or pharmaceutically active compounds |
US20050038473A1 (en) * | 2003-07-14 | 2005-02-17 | Dov Tamarkin | Device and method for the treatment of pilosebaceous disorders |
US20050249685A1 (en) * | 2004-04-27 | 2005-11-10 | Natalia Botchkareva | Reduction of hair growth |
WO2006023010A1 (en) * | 2004-08-18 | 2006-03-02 | Salmedix, Inc. | Alanosine formulations and methods of use |
WO2006069192A1 (en) * | 2004-12-22 | 2006-06-29 | The Gillette Company | Reduction of hair growth with survivin inhibitors |
BRPI0519218A2 (pt) | 2004-12-22 | 2009-01-06 | Gillette Co | reduÇço do crescimento de cabelos ou pÊlos |
US20060263438A1 (en) * | 2005-05-17 | 2006-11-23 | L'oreal | Gelled oil particles for targeting sebaceous glands and/or hair follicles |
US7618956B2 (en) * | 2005-05-31 | 2009-11-17 | The Gillette Company | Reduction of hair growth |
US20070059264A1 (en) * | 2005-09-13 | 2007-03-15 | Ahluwalia Gurpreet S | Reduction of hair growth |
US7727516B2 (en) * | 2006-02-28 | 2010-06-01 | The Procter & Gamble Company | Reduction of hair growth |
FR2944443B1 (fr) | 2009-04-21 | 2012-11-09 | Arkema France | Procede de fabrication de particules de poudre libre a base de polyamide impregnee, et particules de poudre libre a base de polyamide ayant une teneur d'au moins 25% en poids d'au moins un agent cosmetique ou pharmaceutique |
FR2953716B1 (fr) | 2009-12-16 | 2015-03-27 | Oreal | Kit de formulation d'un produit cosmetique |
WO2018118808A1 (en) | 2016-12-19 | 2018-06-28 | The Broad Institute, Inc. | Methods of treating autism spectrum disorders |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4720480A (en) * | 1985-02-28 | 1988-01-19 | Dai Nippon Insatsu Kabushiki Kaisha | Sheet for heat transference |
FR1505475A (fr) * | 1966-10-25 | 1967-12-15 | Docteur Jacques Auclair Lab Du | Composition cosmétique |
BE793306A (fr) * | 1971-12-23 | 1973-04-16 | Waldhof Aschaffenburg Papier | Produit cosmetique |
US4885289A (en) * | 1983-12-12 | 1989-12-05 | Breuer Miklos M | Alteration of character of male beard growth |
US4720489A (en) * | 1984-10-15 | 1988-01-19 | Douglas Shander | Hair growth modification with ornithine decarboxylase inhibitors |
EP0328834A1 (en) * | 1988-02-16 | 1989-08-23 | Merrell Dow Pharmaceuticals Inc. | Novel aspartate transcarbamylase inhibitors |
SE466826B (sv) * | 1990-06-28 | 1992-04-06 | Asea Brown Boveri | Saett att framstaella en metalloxidvaristor med foerbaettrad energihaallfasthet |
-
1990
- 1990-10-24 US US07/603,999 patent/US5095007A/en not_active Expired - Lifetime
-
1991
- 1991-10-22 AT AT91920173T patent/ATE167625T1/de not_active IP Right Cessation
- 1991-10-22 DE DE69129663T patent/DE69129663T2/de not_active Expired - Lifetime
- 1991-10-22 ES ES91920173T patent/ES2117646T3/es not_active Expired - Lifetime
- 1991-10-22 AU AU89289/91A patent/AU662112B2/en not_active Expired
- 1991-10-22 WO PCT/US1991/007839 patent/WO1992007569A1/en active IP Right Grant
- 1991-10-22 JP JP50125792A patent/JP3532192B2/ja not_active Expired - Lifetime
- 1991-10-22 CA CA002094491A patent/CA2094491C/en not_active Expired - Lifetime
- 1991-10-22 EP EP91920173A patent/EP0554363B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2094491C (en) | 2003-01-28 |
EP0554363A4 (en) | 1993-09-15 |
ATE167625T1 (de) | 1998-07-15 |
DE69129663D1 (de) | 1998-07-30 |
EP0554363A1 (en) | 1993-08-11 |
EP0554363B1 (en) | 1998-06-24 |
AU662112B2 (en) | 1995-08-24 |
AU8928991A (en) | 1992-05-26 |
US5095007A (en) | 1992-03-10 |
CA2094491A1 (en) | 1992-04-25 |
DE69129663T2 (de) | 1999-01-21 |
ES2117646T3 (es) | 1998-08-16 |
WO1992007569A1 (en) | 1992-05-14 |
JPH06502648A (ja) | 1994-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3532192B2 (ja) | 毛成長の速度及び特徴の変化 | |
EP0750489B1 (en) | Inhibition of hair growth | |
CA2163534C (en) | Inhibition of hair growth | |
AU681776B2 (en) | Inhibition of hair growth | |
EP0667766B1 (en) | Inhibition of hair growth | |
CA2085885C (en) | Alteration of rate and character of hair growth | |
ES2206609T3 (es) | Reduccion del crecimiento del pelo. | |
EP0612211B1 (en) | Alteration of rate and character of hair growth | |
JP2000501098A (ja) | 毛髪成長の抑制 | |
EP1017358A1 (en) | Reduction of hair growth | |
CA2449822C (en) | Reduction of hair growth | |
JP2765675B2 (ja) | 顆粒状化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040108 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040303 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080312 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090312 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100312 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110312 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110312 Year of fee payment: 7 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120312 Year of fee payment: 8 |